SOX2 and ovarian cancer: There results suggest that hypoxia-NOTCH1-SOX2 signaling axis is an important for maintaining CSCs in ovarian cancer, which may provide a novel opportunity for development of drugs to eliminate CSCs in ovarian cancer patients.